Allergy Therapeutics posts maiden full-year profit and plans expansion
This article was originally published in Scrip
Executive Summary
Allergy Therapeutics has reported its first profitable full-year results for the 12 months ended June 30, 2010. Having "turned the corner" on its financial performance, the UK-based firm will continue to use its "stronger P&L (profit and loss) position as a platform for growth", it told Scrip.